Tag: veterinary productsSort
Sourc CRWESelect : ELRC, PTSH.OB, AVEO, HIRU.PK, MDCA, - Electro Rent Corp, PTS Inc., AVEO Pharmaceuticals, Hiru Corporation
Electro Rent Corporation (NASDAQ:ELRC) previosuly reported that Tanya Jamison has joined Electro Rent as Worldwide Director of Marketing, a newly created position. Jamison comes to Electro Rent from a successful 20-plus year career at Agilent Technologies (a spin-off of Hewlett-Packard Company).
APCVZ, HIRU.PK, PESI, QBAK, - Fresenius Kabi Pharmaceuticals, Hiru Corporation, Perma-Fix Environmental Services
Fresenius Kabi Pharmaceuticals (NASDAQ:APCVZ) previously reported that it has received approval from the U.S. Food and Drug Administration (FDA) to market Topotecan for Injection, and plans to launch immediately. Topotecan for Injection is therapeutically equivalent to the reference-listed drug Hycamtin®, which is currently marketed by the innovator GlaxoSmithKline, plc.
RIMM, COUV.PK, SNDK, HIRU.PK, TRMB, - Research In Motion Limited, Corporate Universe, SanDisk Corp., Hiru Corporation
BOB.V, HIRU, - ( Videos Included) - Global Hunter Corp. and Hiru Corporation - CRWESelect's Stock Report!
MEG, CNO, FMD; TSX.V:BOB And HIRU With New News and Must Watch Videos From BestOTC.com
URZ, HIRU.PK, PIP, TGB, - Uranerz Energy Corp., Hiru Corporation, PharmAthene and Taseko Mines Ltd. Stock Highlight!
Uranerz Energy Corp. (AMEX:URZ) previously reported that it has entered into a sales agreement with Haywood Securities (USA) Inc., pursuant to which the Company may, from time to time, offer and sell shares of its common stock having an aggregate offering price of up to US$20 million through Haywood, acting as agent for any sales made under an “at-the-market” issuance.
VR, GRHU, IT, HIRU.PK, EME, - Validus Holdings, GreenHouse Holdings, Gartner, Hiru Corporation and EMCOR Group Stock Update!
Validus Holdings, Ltd. (NYSE:VR) previously reported net income of $238.5 million, or $2.08 per diluted common share for the three months ended September 30, 2010, compared with net income of $499.2 million, or $5.21 per diluted common share, for the three months ended September 30, 2009.